Save the date:

October 24-26, 2024

Bladder & Kidney Cancer Academy 
Marriott Downtown, Philadelphia, PA

Details coming soon!  

Bladder and Kidney Cancer Academy 2023 

This event took place November 16 - 18, 2023 at the Omni Charlotte Hotel, Charlotte, NC 
To see photos from this event, click here

Bladder and Kidney Cancer Academy
(co-hosted with 
Specialty Networks)

To see photos from the most recent event click here. 

About the Event

Receive an intensive education on the most recent breakthroughs & approvals for all stages of bladder and kidney cancer. Our expert faculty will present, discuss, and debate all available preventative, diagnostic, therapeutic, and management options for bladder and kidney cancer in a highly interactive format, via didactic lectures as well as case-based and panel discussions. The meeting will start with a networking reception on Thursday afternoon and end Saturday mid-morning. See the full agenda here.

Why Attend

You represent the future of our specialty! Throughout this Conference, we ask that you stay engaged and provocative with your feedback. We will continue to collaborate with all of our colleagues in an effort to advance prostate cancer treatments & education.

To Register

If you are interested in attending please contact Katie O'Donnell at [email protected] for more information

Social Media: Use the hashtag #BKCA23 to share your excitement for this meeting on social media!  The most recent Bladder & Kidney Cancer Academy took place last yearTo see photos from the event click here 

  <p>Co-Directors Neal Shore, MD<br />Chief Medical Officer,<br />Surgery & Oncology,<br />GenesisCare<br />Tom Jayram, MD<br />Co-Director, Advanced<br />Therapeutics Center,<br />Urology Associates, PC </p>

Partnership:  Specialty Networks is the organizer of the Bladder & Kidney Cancer Academy in cooperation with LUGPA.

Bladder & Kidney Cancer Academy was created to ensure urology/oncology fellows, residents, and physicians receive optimal education on bladder and kidney cancer diagnosis and management, advanced monitoring and care options, novel pharmaceutical therapies, and surgical advancements.